The content on this site is intended for healthcare professionals only
Optimisation studies in oncology are crucial for understanding dosages and treatment durations post-drug approval. Successful research, especially in immunotherapy, is highlighted from various countries, with India emerging as a potential research hub. Dr Goldstein emphasises practical oncology care rather than just promoting new drugs. A strong call for critical thinking about data and costs in oncology encourages professionals to question traditional practices.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Neoadjuvant cemiplimab shows favourable event-free, disease-free and overall survival rates in patients with resectable CSCC
Adagrasib shows durable clinical benefit in advanced KRAS-mutant NSCLC
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 11th - 17th, 2023
Latest in immunological technologies that can treat, control, and prevent cancer
OncoAlert Round Up for August 4th - 10th, 2023
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
